Myeloma Elderly Prognostic Score ( MEPS ): A Proposed Prognostic Score Integrating Age, Renal Function, Performance Status, and Ultra‐High‐Risk Cytogenetics
Established disease-centered prognostic systems may be less tailored to elderly/non-transplant-eligible (NTE) patients with multiple myeloma (MM), in whom host-related factors such as age, performance status, and renal function strongly influence all-cause outcomes. We developed and evaluated the Myeloma Elderly Prognostic Score (MEPS), a pragmatic four-factor score integrating age ≥ 75 years, renal function < 40 by eGFR or available creatinine clearance (CrCl), ECOG performance status ≥ 2, and ultra-high-risk cytogenetics, using baseline registry data from 881 newly diagnosed NTE MM patients from Greece, with OS analyses performed in the 878 patients with evaluable survival follow-up, and externally evaluated it in an independent Portuguese cohort. In the Greek OS-evaluable cohort, 485 deaths were observed. Median OS by MEPS group was 96, 65, 39, and 15.3 months for scores 0, 1, 2, and ≥ 3, respectively. In a baseline score-level Cox model, each ordinal MEPS category increase was associated with inferior OS (HR 1.74, 95% CI 1.58-1.92; p < 0.001). MEPS showed higher OS discrimination than R2-ISS in the Greek cohort (C-index 0.655 vs. 0.602; bootstrap delta 0.053, 95% CI 0.021-0.085). The Portuguese validation dataset included 300 patients, of whom 290 were evaluable for the primary OS analysis, with 151 deaths. Median OS was 59.6 months (95% CI 52.4-75.7), and MEPS again showed higher discrimination than R2-ISS (C-index 0.729 vs. 0.647; bootstrap delta 0.082, 95% CI 0.041-0.127). MEPS provides a simple all-cause prognostic tool for elderly/NTE MM, complementing biologically oriented staging with routinely available host-related variables.
Authors
- Efstathios Kastritis (ORCID: https://orcid.org/0000-0001-8191-5832)
- Emmanouil Spanoudakis (ORCID: https://orcid.org/0000-0003-4985-5862)
- Cristina João (ORCID: https://orcid.org/0000-0002-3978-766X)
- M Gavriatopoulou
- Adriana Isabel Roque (ORCID: https://orcid.org/0000-0003-4194-9119)
- Ioannis Ntanasis‐Stathopoulos (ORCID: https://orcid.org/0000-0002-6328-9783)
- Meletios Α. Dimopoulos (ORCID: https://orcid.org/0000-0001-8990-3254)
- Vasiliki Palaska
- Eirini Katodritou (ORCID: https://orcid.org/0000-0001-9404-807X)
- Evangelos Terpos (ORCID: https://orcid.org/0000-0001-5133-1422)
- Elpiniki Rentzeperi
- Aikaterini Daiou
- Maria Kotsopoulou (ORCID: https://orcid.org/0000-0003-1895-6935)
- Joana Vieira (ORCID: https://orcid.org/0000-0002-7245-3012)
- Rui Bergantim (ORCID: https://orcid.org/0000-0002-7811-9509)
- Dimitra Dalampira (ORCID: https://orcid.org/0000-0001-6987-4716)
- Κonstantinos Κostikas (ORCID: https://orcid.org/0000-0003-0774-3942)
- Foteini Theodorakakou (ORCID: https://orcid.org/0000-0001-6926-0351)
- Bruna Ferreira (ORCID: https://orcid.org/0000-0002-5612-5385)
- Maria Tsirogianni
- Catarina Isabel Batista Geraldes dos Santos
- Sosana Delimpasi (ORCID: https://orcid.org/0000-0001-7523-7510)
- Vasiliki Douka
- Dionysios Stoumpos
- Vasiliki Tara
- Xanthippi Dimitriadou
- Elisabeth Karadrakonti
- Graca Luiza O. P. Neto Vasconcelos Esteves
- Helena Martins
Institutions
- Champalimaud Foundation (PT)
- University of Lisbon (PT)
- Democritus University of Thrace (GR)
- Universidade do Porto (PT)
- National and Kapodistrian University of Athens (GR)
- Hospitais da Universidade de Coimbra (PT)
- Hospital de São João (PT)
- Theageneio General Hospital (GR)
- BC Platforms (Finland) (FI)
- Escola Superior de Tecnologia da Saúde de Coimbra (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Nova Medical (United States) (US)
- St Savas Hospital (GR)
- Metaxa Hospital (GR)
- Hospital de Santa Maria (PT)
- G. Papanikolaou General Hospital (GR)
- i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto (PT)
- University Hospital of Alexandroupolis (GR)
- Evangelismos Hospital (GR)
- University of Coimbra (PT)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- American Journal of Hematology
- Published
- 2026-08-24
- DOI
- https://doi.org/10.1002/ajh.70479
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00